Loading clinical trials...
Loading clinical trials...
A Phase 1 Study of Safety and Tolerability of AutoSynVax™ Vaccine as a Single Agent in Subjects With Advanced Cancer
Conditions
Interventions
AutoSynVax™ vaccine
Locations
2
United States
School of Medicine at the University of Miami
Miami, Florida, United States
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Start Date
January 1, 2017
Primary Completion Date
December 1, 2018
Completion Date
December 1, 2019
Last Updated
June 2, 2020
NCT04657068
NCT04900818
NCT05004116
NCT06440005
NCT07246954
NCT06242470
Lead Sponsor
Agenus Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions